FY2025 · ended Dec 31, 2025 · Revenue $200.93M, +20.2% YoY · Filed Feb 24, 2026
Si-Bone, Inc. (SIBN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $200.9 million and a net loss of $18.9 million. Free cash flow was -$9.1 million. As of Sep 30, 2026 it held $35.3 million in cash and investments and $42.8 million in total debt.
Revenue (TTM)
$220.65M
+14.0% vs year-ago TTM
Net income (TTM)
$-13.69M
+37.1% vs year-ago TTM
Operating cash flow (TTM)
$6.08M
+596.6% vs year-ago TTM
Free cash flow (TTM)
$-4.19M
+60.5% vs year-ago TTM
EPS (TTM)
$-0.31
+39.5% vs year-ago TTM
Dividend per share
$0.00
Shares outstanding
44.17M
+4.0% vs prior year
Net cash
$-7.49M
as of Sep 30, 2026
Operating margin
-7.6%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SIBN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1459839
- Former names
- SI-Bone Inc. (until Sep 30, 2011)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $200.9M | $167.2M | $138.9M | $106.4M | $90.2M |
| Operating income | -$22.3M | -$35.2M | -$46.9M | -$59.6M | -$51.7M |
| Net income | -$18.9M | -$30.9M | -$43.3M | -$61.3M | -$56.6M |
| Diluted EPS | -$0.44 | -$0.75 | -$1.13 | -$1.79 | -$1.71 |
| Operating cash flow | -$675,000 | -$12.4M | -$18.7M | -$41.7M | -$39.5M |
| Free cash flow | -$9.1M | -$22.9M | -$26.5M | -$51.2M | -$45.9M |
| Total assets | $238.6M | $230.4M | $230.4M | $157.6M | $190.5M |
| Total liabilities | $61.0M | $63.5M | $61.0M | $59.2M | $56.1M |
| Stockholders' equity | $177.5M | $167.0M | $169.4M | $98.3M | $134.4M |
| Cash and investments | $42.2M | $34.9M | $33.3M | $97.3M | $147.0M |
| Total debt | $36.7M | $37.5M | $39.0M | $39.4M | $40.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Sep 11, 2026 | Aug 21, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Material agreement, New debt, Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
All 782 Si-Bone, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.